| C03DA04 |
Eplerenone |
Carditrust |
Film coated tablet |
25 |
mg |
30 |
Actavis Group PTC ehf., Исландия |
50 |
mg |
- |
26.15 |
0.89767 |
13.47 |
25% |
3.36 |
|
I50.0,I50.1 |
НСР-7498/13.11.2015.; НСР-17702/10.01.2019 |
02.09.2019 |
|
|
Активен |
4100 |
| C03DA04 |
Eplerenone |
Eplerenone Accord |
Film coated tablet |
25 |
mg |
28 |
Accord Healthcare Limited, Обединено Кралство |
50 |
mg |
- |
31.97 |
0.89767 |
12.57 |
25% |
3.14 |
|
I50.0,I50.1 |
НСР-16720/30.08.2018 |
02.09.2019 |
|
|
Активен |
16258 |
| C03DA04 |
Eplerenone |
Eplerenone Accord |
Film coated tablet |
50 |
mg |
28 |
Accord Healthcare Limited, Обединено Кралство |
50 |
mg |
- |
31.97 |
0.89767 |
25.13 |
25% |
6.28 |
|
I50.0,I50.1 |
НСР-16720/30.08.2018 |
02.09.2019 |
|
|
Активен |
16259 |
| C03DA04 |
Eplerenone |
Eplerium |
Film coated tablet |
25 |
mg |
30 |
Stada Arzneimittel AG, Германия |
50 |
mg |
- |
29.1 |
0.89767 |
13.47 |
25% |
3.36 |
|
I50.0,I50.1 |
НСР-11257/22.12.2016 |
02.09.2019 |
|
|
Активен |
15553 |
| C03DA04 |
Eplerenone |
Eplerium |
Film coated tablet |
25 |
mg |
30 |
Stada Arzneimittel AG, Германия |
50 |
mg |
- |
60.08 |
4.00533 |
60.08 |
25% |
15.02 |
|
I50.0,I50.1 |
НСР-2909/05.03.2014; НСР-4777/13.10.2014 |
02.11.2014 |
|
|
Заличен |
2559 |
| C03DA04 |
Eplerenone |
Espiro |
Film coated tablet |
50 |
mg |
30 |
Medana Pharma S.A., Полша |
50 |
mg |
- |
26.93 |
0.89767 |
26.93 |
25% |
6.73 |
|
I50.0,I50.1 |
НСР-19374/02.08.2019 |
02.09.2019 |
|
|
Активен |
16654 |
| C03DA04 |
Eplerenone |
Espiro |
Film coated tablet |
25 |
mg |
30 |
Medana Pharma S.A., Полша |
50 |
mg |
- |
21.25 |
0.89767 |
13.47 |
25% |
3.36 |
|
I50.0,I50.1 |
НСР-19374/02.08.2019 |
02.09.2019 |
|
|
Активен |
16653 |
| C03DA04 |
Eplerenone |
INSPRA |
Film coated tablet |
25 |
mg |
30 |
Pfizer Enterprises SARL, Люксембург |
50 |
mg |
- |
91.25 |
4.00533 |
60.08 |
25% |
15.02 |
|
I50.0,I50.1 |
НСР-3247/14.04.2014 |
16.05.2014 |
08.09.2012 |
|
Заличен |
614 |
| C03DA04 |
Eplerenone |
INSPRA |
Film coated tablet |
25 |
mg |
20 |
Pfizer Enterprises SARL, Люксембург |
50 |
mg |
- |
60.84 |
4.00533 |
40.05 |
25% |
10.01 |
|
I50.0,I50.1 |
НСР-3247/14.04.2014 |
16.05.2014 |
08.09.2012 |
|
Заличен |
613 |
| C03EA01 |
Triamterene/Hydrochlorothiazide |
C03EA01 Triamterene/Hydrochlorothiazide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C03EA01 |
Triamterene, Hydrochlorothiazide |
DIURETIDIN |
Tablet |
25mg/12.5mg |
mg |
50 |
Актавис EАД, България |
1 |
tabl |
- |
3.82 |
0.0764 |
3.82 |
50% |
1.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6 |
НСР-19009/20.06.2019 |
02.08.2019 |
08.09.2012 |
|
Активен |
239 |
| C03EA01 |
Triamterene, Hydrochlorothiazide |
TRIAMPUR COMPOSITUM |
Tablet |
25 mg/12,5 mg |
mg |
50 |
Екофарм Груп АД, България |
1 |
tabl |
- |
6.55 |
0.0764 |
3.82 |
50% |
1.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6 |
КЦPP-409/29.03.2012 г.; НСР-3033/21.03.2014; КП-74/01.10.2018 и НСР-15929/15.06.2018 |
02.08.2019 |
08.09.2012 |
|
Активен |
2651 |
| C04AD03 |
Pentoxifylline |
C04AD03 Pentoxifylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C04AD03 |
Pentoxifylline |
Agapurin |
Film coated tablet |
100 |
mg |
60 |
Zentiva a.s., Словакия |
1000 |
mg |
- |
6.11 |
0.34333 |
2.06 |
25% |
0.52 |
|
G63.2,H36.0,I27.0,I69.3,I69.4,I69.8,I73.1 |
|
02.08.2016 |
08.09.2012 |
|
Активен |
2491 |
| C04AD03 |
Pentoxifylline |
AGAPURIN SR 400 |
Prolonged release tablet |
400 |
mg |
60 |
Zentiva a.s., Словакия |
1000 |
mg |
- |
11.2 |
0.34333 |
8.24 |
25% |
2.06 |
|
G63.2,H36.0,I27.0,I69.3,I69.4,I69.8,I73.1 |
КЦРР-1180/08.08.2012 г. |
02.08.2016 |
08.09.2012 |
|
Активен |
2671 |
| C04AD03 |
Pentoxifylline |
AGAPURIN SR 400 |
Prolonged release tablet |
400 |
mg |
20 |
Zentiva a.s., Словакия |
1000 |
mg |
- |
2.99 |
0.34333 |
2.75 |
25% |
0.69 |
|
G63.2,H36.0,I27.0,I69.3,I69.4,I69.8,I73.1 |
КЦРР-1179/08.08.2012 г.; НСР-7766/28.12.2015; НСР-18286/28.03.2019 |
02.05.2019 |
08.09.2012 |
|
Активен |
2827 |
| C04AD03 |
Pentoxifylline |
Agapurin SR 600 |
Prolonged release tablet |
600 |
mg |
20 |
Zentiva a.s., Словакия |
1000 |
mg |
- |
4.12 |
0.34333 |
4.12 |
25% |
1.03 |
|
G63.2,H36.0,I27.0,I69.3,I69.4,I69.8,I73.1 |
КП-87/16.06.2016 и НСР-8553/24.03.2016 |
02.08.2016 |
08.09.2012 |
|
Активен |
2645 |
| C04AD03 |
Pentoxifylline |
PENTILIN |
Prolonged release tablet |
400 |
mg |
20 |
KRKA, d.d., Словения |
1000 |
mg |
- |
4.78 |
0.46667 |
3.73 |
25% |
0.93 |
|
G63.2,H36.0,I27.0,I69.3,I69.4,I69.8,I73.1 |
НСР-2689/03.02.2014 |
02.03.2014 |
08.09.2012 |
|
Заличен |
289 |
| C04AD03 |
Pentoxifylline |
PentoHEXAL600 |
Prolonged release tablet |
600 |
mg |
30 |
Hexal AG, Германия |
1000 |
mg |
- |
11.17 |
0.34333 |
6.18 |
25% |
1.55 |
|
G63.2,H36.0,I27.0,I69.3,I69.4,I69.8,I73.1 |
|
02.08.2016 |
08.09.2012 |
|
Активен |
517 |
| C04AD03 |
Pentoxifylline |
PENTOXIFYLLIN-TCHAIKAPHARMA |
Prolonged release tablet |
400 |
mg |
20 |
Чайкафарма Висококачествените лекарства АД, България |
1000 |
mg |
- |
5.95 |
0.34333 |
2.75 |
25% |
0.69 |
|
G63.2,H36.0,I27.0,I69.3,I69.4,I69.8,I73.1 |
НСР-5068/21.11.2014; НСР-18107/07.03.2019 |
02.04.2019 |
08.09.2012 |
|
Активен |
3367 |
| C04AD03 |
Pentoxifylline |
PENTOXIPHARM |
Gastro resistant tablet |
100 |
mg |
60 |
Софарма АД, България |
1000 |
mg |
- |
4.56 |
0.34333 |
2.06 |
25% |
0.52 |
|
G63.2,H36.0,I27.0,I69.3,I69.4,I69.8,I73.1 |
НСР-2749/17.02.2014; НСР-18791/21.05.2019 |
02.07.2019 |
08.09.2012 |
|
Активен |
2537 |
| C04AD03 |
Pentoxifylline |
PENTOXIPHYLLIN ACTAVIS |
Prolonged release tablet |
400 |
mg |
20 |
Актавис EАД, България |
1000 |
mg |
- |
5.23 |
0.46667 |
3.73 |
25% |
0.93 |
|
G63.2,H36.0,I27.0,I69.3,I69.4,I69.8,I73.1 |
НСР-9142/27.04.2016 |
02.06.2016 |
08.09.2012 |
|
Заличен |
223 |
| C04AD03 |
Pentoxifylline |
Vasonit |
Prolonged release tablet |
600 |
mg |
20 |
G. L. Pharma GmbH, Австрия |
1000 |
mg |
- |
9.2 |
0.34333 |
4.12 |
25% |
1.03 |
|
G63.2,H36.0,I27.0,I69.3,I69.4,I69.8,I73.1 |
НСР-6924/12.08.2015 |
02.08.2016 |
|
|
Активен |
4062 |
| C04AD03 |
Pentoxifylline |
Vasonit |
Prolonged release tablet |
600 |
mg |
20 |
G. L. Pharma GmbH, Австрия |
1000 |
mg |
- |
9.2 |
0.46667 |
5.6 |
25% |
1.4 |
|
G63.2,H36.0,I27.0,I69.3,I69.4,I69.8,I73.1 |
КЦРР-1356/05.09.2012 г.; НСР-5426/16.01.2015 г. |
16.02.2015 |
|
|
Заличен |
1380 |
| C04AE02 |
Nicergoline |
C04AE02 Nicergoline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|